Is T. Rowe Price Personal Strategy Income (PRSIX) a Strong Mutual Fund Pick Right Now?
Werte in diesem Artikel
There are plenty of choices in the Allocation Balanced category, but where should you start your research? Well, one fund that might be worth investigating is T. Rowe Price Personal Strategy Income (PRSIX). PRSIX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance.ObjectivePRSIX is classified in the Allocation Balanced segment by Zacks, which is an area full of possibilities. Here, investors are able to get a good head start with diversified mutual funds, and play around with core holding options for a portfolio of funds. Allocation Balanced funds look to invest across a balance of asset types, like stocks, bonds, and cash, though including precious metals or commodities is not unusual; these funds are mostly categorized by their respective asset allocation.History of Fund/ManagerT. Rowe Price is based in Baltimore, MD, and is the manager of PRSIX. Since T. Rowe Price Personal Strategy Income made its debut in July of 1994, PRSIX has garnered more than $1.02 billion in assets. Charles Shriver is the fund's current manager and has held that role since May of 2011.PerformanceOf course, investors look for strong performance in funds. This fund carries a 5-year annualized total return of 7.41%, and is in the middle third among its category peers. If you're interested in shorter time frames, do not dismiss looking at the fund's 3 -year annualized total return of 3.68%, which places it in the top third during this time-frame.It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Compared to the category average of 12.03%, the standard deviation of PRSIX over the past three years is 8.61%. The standard deviation of the fund over the past 5 years is 8.36% compared to the category average of 12.66%. This makes the fund less volatile than its peers over the past half-decade.Risk FactorsInvestors should note that the fund has a 5-year beta of 0.46, which means it is hypothetically less volatile than the market at large. Another factor to consider is alpha, as it reflects a portfolio's performance on a risk-adjusted basis relative to a benchmark-in this case, the S&P 500. PRSIX has generated a negative alpha over the past five years of -2.42, demonstrating that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.ExpensesAs competition heats up in the mutual fund market, costs become increasingly important. Compared to its otherwise identical counterpart, a low-cost product will be an outperformer, all other things being equal. Thus, taking a closer look at cost-related metrics is vital for investors. In terms of fees, PRSIX is a no load fund. It has an expense ratio of 0.38% compared to the category average of 0.82%. Looking at the fund from a cost perspective, PRSIX is actually cheaper than its peers.Investors need to be aware that with this product, the minimum initial investment is $2,500; each subsequent investment needs to be at least $100.Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included.Bottom LineOverall, T. Rowe Price Personal Strategy Income ( PRSIX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, T. Rowe Price Personal Strategy Income ( PRSIX ) looks like a good potential choice for investors right now.Want even more information about PRSIX? Then go over to Zacks.com and check out our mutual fund comparison tool, and all of the other great features that we have to help you with your mutual fund analysis for additional information. Want to learn even more? We have a full suite of tools on stocks that you can use to find the best choices for your portfolio too, no matter what kind of investor you are.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (PRSIX): Fund Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Quelle: Zacks
Nachrichten zu Microstrategy
Analysen zu Microstrategy
Datum | Rating | Analyst | |
---|---|---|---|
11.02.2019 | Microstrategy A Buy | BWS Financial | |
27.10.2017 | Microstrategy A Buy | Mizuho | |
28.07.2017 | Microstrategy A Hold | Deutsche Bank AG | |
16.11.2016 | Microstrategy A Buy | Mizuho | |
11.01.2016 | Microstrateg a Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
11.02.2019 | Microstrategy A Buy | BWS Financial | |
27.10.2017 | Microstrategy A Buy | Mizuho | |
16.11.2016 | Microstrategy A Buy | Mizuho | |
11.01.2016 | Microstrateg a Buy | Deutsche Bank AG | |
11.12.2015 | Microstrateg a Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
28.07.2017 | Microstrategy A Hold | Deutsche Bank AG | |
19.10.2015 | Microstrateg a Hold | Lake Street | |
31.10.2012 | Microstrateg a neutral | ROTH Capital Partners, LLC | |
30.10.2012 | Microstrateg a neutral | UBS AG | |
31.07.2012 | Microstrateg a neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
16.03.2005 | Update Microstrategy Inc.: Sell | Wedbush Morgan | |
09.02.2005 | Update Microstrategy Inc.: Sell | Deutsche Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Microstrategy nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen